Q4 2015 13F Holders as of 12/31/2015
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
1.77B
-
Number of holders
-
1624
-
Total 13F shares, excl. options
-
1.11B
-
Shares change
-
-30.9M
-
Total reported value, excl. options
-
$66B
-
Value change
-
-$1.78B
-
Put/Call ratio
-
1.26
-
Number of buys
-
666
-
Number of sells
-
-757
-
Price
-
$59.24
Significant Holders of AbbVie Inc. - Common Stock (ABBV) as of Q4 2015
1,789 filings reported holding ABBV - AbbVie Inc. - Common Stock as of Q4 2015.
AbbVie Inc. - Common Stock (ABBV) has 1,624 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 1.11B shares
of 1.77B outstanding shares and own 63.07% of the company stock.
Largest 10 shareholders include VANGUARD GROUP INC (99.6M shares), Capital Research Global Investors (77.6M shares), STATE STREET CORP (69.3M shares), FMR LLC (44.2M shares), BlackRock Institutional Trust Company, N.A. (42.5M shares), BANK OF AMERICA CORP /DE/ (27.5M shares), JANUS CAPITAL MANAGEMENT LLC (26.8M shares), Bank of New York Mellon Corp (23.7M shares), NORTHERN TRUST CORP (22.3M shares), and BlackRock Fund Advisors (20.2M shares).
This table shows the top 1624 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.